Abstract: A method is provided. An airship is maneuvered to a desired location and oriented with the thruster such that ambient wind is traveling in a direction that is substantially parallel to the longitudinal axis of the fuselage. The airflow from the ambient wind is straightened with the flow straightener to generate a substantially laminar flow. The turbine is engaged with the airflow generated by the ambient wind to generate electricity, and the electricity generated by the turbine is rectified with the rectifier and stored in the storage array.

Abstract: This disclosure presents systems, devices, and methods that use magnetometers to measure large magnetic moments with strong magnetic anisotropy. A torque magnetometer may include an actuator driven by a motor, a load cell coupled to the actuator, a rotatable spool having a platform configured to hold a sample of a superconductor material, where the rotatable spool is coupled to the load cell by a first line, a pulley, and a second line extending between the rotatable spool and a counterweight, where the second line is positioned on the pulley. Movement of the actuator may cause the rotatable spool to rotate an angle of the platform relative to a magnetic field about the rotatable spool, and the load cell is capable of measuring the tension on the first line.

Abstract: A method is provided. A notice is received from a mobile device indicating that typing within a texting application has occurred substantially simultaneously as walking has been detected. The notice includes a timestamp of when the typing and the detection of walking occurred. A position of the mobile device is triangulated for the timestamp, and a determination is made as to whether the typing and the detection of walking occurred within a predetermined target area using at least a portion of data calculated from the step of triangulating.

Abstract: Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.

Abstract: Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.

Abstract: Combined therapy for a solid tumor, comprising an antibody that binds human galectin-9 (anti-Gal9 antibody, e.g, G9.2-17), and one or more chemotherapeutics, for example, gemcitabine, paclitaxel, or a combination thereof.

Abstract: Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.

Abstract: Disclosed herein are anti-Galectin-9 antibodies and methods of using in modulating (e.g., increasing) immune responses in a subject, either taken alone or in combination with an immune checkpoint inhibitor, such as a PD-1 inhibitor.

Abstract: Disclosed herein are methods for treating solid tumors (e.g., pancreatic adenocarcinoma (PDA), colorectal cancer (CRC), hepatocellular carcinoma (HCC)), or Cholangiocarcinoma and others), including, but not limited to, metastatic tumors, using an anti-Galectin-9 antibody.

Abstract: Disclosed herein are methods for identifying a subject as having certain solid cancers such as breast cancer, colorectal colon cancer, or non-small cell lung cancer, or being at risk for the cancer based on the level of Galectin-9 in a biological sample (e.g., a blood sample) from a subject suspected of having the solid cancer.

Abstract: Disclosed herein are antibodies specific to a delta-1 chain of a ?? T cell receptor and methods of using such for modulating ?? T cell bioactivity. Such anti-Delta 1 antibodies may also be used to treat diseases associated with ?? T cell activation, such as solid tumors, or for detecting presence of ??1 T cells.

Abstract: A fan shroud for a pump assembly having a pump, a motor and a drive. The fan shroud includes a fan shroud end cap coupled to a rear bell end of the motor, the fan shroud end cap having a vented surface for receiving cool air drawn by a motor fan during operation of the motor. The fan shroud further includes an extended shell sidewall extending from the fan shroud end cap across a length of the motor, and the fan shroud end cap and the extended shell sidewall are configured to surround the motor.

Abstract: The application relates to methods based on modulating pancreatic and/or gastrointestinal microbiota and related antifungal compositions. Specifically, the application relates to the use of microbiome for prevention, treatment and diagnosis of pancreatic cancers or tumors, such as pancreatic ductal adenocarcinoma.

Abstract: Example shoe manufacturing methods and related computer readable medium for implementing a portion of said manufacturing methods are disclosed herein. In some examples, the method includes placing an upper member about an upper portion of a last, wherein the last is a form for the shoe. In addition, the method includes producing a lasting based on data relating to a foot of a user, and attaching the lasting to the upper member, wherein the lasting extends over a lower portion of the last. Further, the method includes molding a sole onto the lasting and the upper member; and removing the last from the upper member.

Abstract: Example shoe manufacturing methods and related computer readable medium for implementing a portion of said manufacturing methods are disclosed herein. In some examples, the method includes producing a lower portion of a last based on data relating to a foot of a user. In addition, the method includes placing an upper member about the last such that a lasting of the upper member extends over the lower portion of the last. Further, the method includes producing a midsole element based on the data relating to the foot of the user, and attaching the midsole element to the upper member such that the lasting is disposed between the lower portion of the last and the midsole element.

Abstract: A cationic compatible metal oxide and oral care compositions containing the metal oxide are disclosed. Preferably, the oral care compositions contain a cationic compatible metal oxide and a cationic ingredient, such as for example, a cationic antibacterial agent such as cetyl pyridinium chloride (“CPC”). The cationic compatible metal oxide, e.g. silica, comprise metal oxide particles having a substantially negative surface charge and a vitamin deposited onto or reacted with the surface of the metal oxide particles in an amount sufficient to provide a substantially positive surface charge on the metal oxide particle. Processes for making and using the vitamin modified metal oxide in oral care compositions are also disclosed.

Abstract: A fin for use on a surfboard, the fin comprising: a leading edge, a trailing edge, and a base, the base comprising at least one mount for mounting the fin onto a surfboard; a first and a second outer fin surface which meet along the leading edge and the trailing edge and abut the base; and a first ridge protruding laterally from the first outer fin surface, and/or a second ridge protruding laterally from the second outer fin surface; wherein the shape and configuration of the fin creates an area of lower water pressure around and in front of the fin, as well as disrupting and/or reducing the size of trailing vortices, resulting in additional forward thrust for the board on which the fin is mounted.

Abstract: A fin for use on a surfboard, the fin comprising: a leading edge, a trailing edge, and a base, the base comprising at least one mount for mounting the fin onto a surfboard; a first and a second outer fin surface which meet along the leading edge and the trailing edge and abut the base; and a first ridge protruding laterally from the first outer fin surface, and/or a second ridge protruding laterally from the second outer fin surface; wherein the shape and configuration of the fin creates an area of lower water pressure around and in front of the fin, as well as disrupting and/or reducing the size of trailing vortices, resulting in additional forward thrust for the board on which the fin is mounted.

Abstract: The present invention relates to a resiliently flexible fin for a surfboard or another surface watercraft, the resiliently flexible fin comprising a titanium or titanium alloy core and an opening in the trailing edge that enables a portion of the rear of the fin to resiliently flex against the force of water as the surfboard is turned, which can generate additional forward thrust for the surfboard as the surfboard exits the turn and the fin returns to its unflexed state displacing water in its path with force.

Abstract: A method is provided. A notice is received from a mobile device indicating that typing within a texting application has occurred substantially simultaneously as walking has been detected. The notice includes a timestamp of when the typing and the detection of walking occurred. A position of the mobile device is triangulated for the timestamp, and a determination is made as to whether the typing and the detection of walking occurred within a predetermined target area using at least a portion of data calculated from the step of triangulating.